Cetaphil® Skin Care Products
March 2017: This action was dismissed When a complaint is dismissed with prejudice, it cannot be refiled., the reasons for which have not been disclosed.
September 2016: A false advertising class-action lawsuit was filed against Galderma Laboratories in September 2016 (and transferred to federal court in October 2016) for allegedly misleadingly representing that Cetaphil® skin care products treat or mitigate eczema when, in reality, they do not. (Greenberg et al v. Galderma Laboratories, L.P. and Does 1-100, Case No. 16-cv-6090, N. D. CA.)
Class-Action Tracker
The Latest
On Shoes
Lawsuit pokes holes in company’s Swiss branding.
Junk Fees at JFK, LaGuardia and Newark Airports
Why are these airport vendors slyly charging consumers for “employee benefits”?
FTC Takes TruHeight’s Growth Claims Down a Few Pegs
Supplement maker agrees to pay $750K to settle deceptive health claims lawsuit.
FTC Cracks Down on Forever Living Following Years of Deception
Settlement comes after TINA.org exposed thousands of deceptive income claims.
What You Should Know about Home Projectors
TINA.org sheds light on confusing and misleading brightness claims.